Which states does Willow serve?

Thirty-six, according to its FAQ: Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin and Wyoming. Its help center gives a slightly different list, with Puerto Rico in place of Wyoming, and New Mexico and Vermont appear neither on the FAQ list nor on the About page's list of states not yet served. Confirm your state with Willow before starting the questionnaire.

Can I use Willow if I have type 2 diabetes?

No. Willow states that it cannot currently accept patients with diabetes, although pre-diabetes and high blood pressure are accepted. That rules out a large group of people for whom GLP-1 drugs are commonly prescribed, so if you have diabetes, a service that treats it, or your own doctor, is the route.

Is Willow's $299 a good price for compounded semaglutide?

It is at the upper end. Mondae charges $87 a month month-to-month for compounded semaglutide, and MEDGm lists injections from $179 and tablets from $249. What the higher price buys at Willow is a published price for every dose, the pharmacies named with addresses, a named prescribing practice, and physician messaging included, with no prepay commitment. Whether that is worth roughly $120 to $210 a month more is a judgment only you can make.

Can I get NAD⁺ from Willow without a GLP-1?

The site does not say. The NAD⁺ page lists a $199 monthly price and a dosing schedule, but its sign-up steps are headed "three simple steps to weight loss care", and Willow's help article on NAD⁺ describes it as support during GLP-1 treatment. Ask before you start the questionnaire. On the evidence, injected NAD⁺ has no controlled human outcome trials, so treat the energy and complexion claims as marketing.

Willow is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide, Compounded tirzepatide and an oral form. Its stated availability: 36 states listed. What it publishes up front: Semaglutide injection or tablet from $299/mo; tirzepatide $399–$549/mo by dose. Month-to-month, 36 states. It is cash-pay and states it does not bill insurance. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. Those are the provider's own published claims rather than checks we could run ourselves, so get the ones that matter to you confirmed in writing before you pay.

Is Willow expensive compared with other GLP-1 telehealth providers?

Willow publishes a starting figure of $299/mo. Across the 51 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $299 with a median of $179, which puts Willow above the median. The other 33 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

PartnerUpdated September 2026

Willow review

Prices every dose

A GLP-1 service that publishes its price at every dose and names its pharmacies, from $299 a month in 36 states.

Our verdict

Willow is expensive at the entry level and honest about why the price moves. Semaglutide starts at $299 a month and tirzepatide at $399, both month-to-month, and instead of a single "from" figure the company publishes a per-dose price sheet: tirzepatide injection climbs to $549 at the top of its ladder, and you can see that before you start. Disclosure is well above what a reader should expect: five partner pharmacies named with street addresses, the physician practice named, and a plain statement that its chief medical officer, who also leads that practice, holds equity in the company. Three things count against it. It serves 36 states, not 50. It does not accept patients with diabetes. And a few of its own pages disagree with each other on details: the semaglutide tablet price, the state list and the refund window.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →Semaglutide injection or tablet from $299/mo; tirzepatide $399–$549/mo by dose. Month-to-month, 36 states

At a glance

Category: GLP-1 telehealth
Access: Semaglutide injection or tablet from $299/mo; tirzepatide $399–$549/mo by dose. Month-to-month, 36 states
Medications: Compounded semaglutide · Compounded tirzepatide · Oral
Insurance: Cash-pay, no insurance
Visit: Quiz intake / Async intake
Availability: 36 states listed
LegitScript: Claimed by provider
Updated: September 2026

What it is

An online weight-loss service operated by Willow Health Services, Inc., a Houston, Texas company, selling compounded semaglutide and tirzepatide by weekly injection or daily under-the-tongue tablet, a combination semaglutide/tirzepatide tablet, and a compounded NAD⁺ injection. The company describes itself as a technology platform rather than a medical provider: prescribing is done by physicians of an affiliated practice, which its consent form names as Willow Medical of California, P.C., and medication is dispensed by partner pharmacies. Its mission statement is written for women ("dedicated to improving women's overall wellbeing"), though nothing in the eligibility rules limits it to women. It claims more than 100,000 patients and displays a LegitScript seal (ID 2142601).

How it works

Asynchronous. You answer an online health questionnaire, upload a government-issued photo ID, and a U.S.-licensed physician reviews it, writes a treatment plan and, if you qualify, prescribes the same day. After that, you message your physician through a patient portal at no extra charge, and Willow says you will usually keep the same physician. It publishes the names of its physicians on a dedicated page. Once a prescription is written, pharmacy processing takes two to four business days and delivery another two to three by FedEx or UPS. Eligibility is stricter than many GLP-1 services: adults 18 and over who are not pregnant or breastfeeding, with no eating disorder, recent bariatric surgery, gallbladder disease, pancreatitis, or history of medullary thyroid cancer or MEN2 — and no diabetes, although pre-diabetes and high blood pressure are accepted. The five partner pharmacies are named with addresses in the terms of service: Red Rock Home Pharmacy (Springville, Utah), Epiq Pharmacy (Richardson, Texas), Absolute Pharmacy (Lutz, Florida), The Pharmacy Hub (Miami, Florida) and Empower Pharmacy (Houston, Texas). The site does not say which pharmacy fills which product, or whether each is a 503A or 503B facility.

Pricing transparency

A monthly subscription that renews automatically, with medication, the physician, portal messaging and shipping included and no insurance billed; HSA and FSA cards are accepted. There are no multi-month prepay tiers, so the posted price is the month-to-month price. Willow's help-center price sheet lists every dose. Semaglutide injection is $299 a month at every dose up to 3.5 mg and $399 at 7 mg. Tirzepatide injection is $399 at 2.125, 4.25 and 6.375 mg, $499 at 8.5 and 11 mg, $524 at 13.5 mg and $549 at 17 mg. Tirzepatide tablets are $399 at 6 and 10 mg and $459 at 20 mg; the semaglutide/tirzepatide combination tablet is $399 or $459. Semaglutide tablets are listed as $299 at all dosages on the price sheet but as $299–$399 in Willow's own tablet guide, so ask which applies to your dose. NAD⁺ is $199 a month. One extra fee is disclosed: if you have the prescription sent to an outside pharmacy, a $150-a-month platform fee applies and you pay for the medication separately. To stop a refill, cancel at least two business days before the next processing date; the FAQ and help center promise a full refund if you cancel before the prescription is sent to the pharmacy, while the refund section of the consent form says full refunds apply only within 24 hours of the order.

Branded vs compounded

Compounded semaglutide and tirzepatide, by weekly injection or as a daily tablet dissolved under the tongue, plus a combination tablet containing both, and a compounded NAD⁺ injection. Willow's compounding disclosures are clear and appear on every product page, and its tablet guide adds a line many sellers leave out: "There is no FDA-approved oral-dissolving formulation of semaglutide or tirzepatide." On the evidence: the weight-loss trial data for semaglutide and tirzepatide belongs to the branded injections, and the FDA does not test compounded versions for potency or purity. The under-the-tongue tablets are a further step removed. The only approved oral semaglutide is a tablet you swallow, built around an absorption enhancer, and no approved oral tirzepatide exists, so how much of a dissolving-tablet dose reaches the bloodstream has not been shown in published human trials. Willow's statement that the tablet "bypass[es] the digestive system and liver" describes the route, not a demonstrated dose. Its tirzepatide injection ladder runs to 17 mg, above the 15 mg top dose on Zepbound's label and beyond the doses the pivotal trials tested. For NAD⁺, Willow promises "youthful energy" and "a brighter, more vibrant-looking complexion". Injected NAD⁺ has no controlled human outcome trials, and the oral precursors NR and NMN, the forms with human data, show a raised blood level rather than a clinical benefit. Individual results vary.

Pros and watch-outs

What we like

A price is published for every dose, so the cost of moving up a dose is known before you start
No prepay tiers: $299 for semaglutide and $399 for tirzepatide are month-to-month prices
Five partner pharmacies named with street addresses, and the prescribing practice named
The chief medical officer's equity stake in the company is disclosed in writing
Injection and needle-free tablet options for both semaglutide and tirzepatide
Displays a LegitScript seal; HSA and FSA cards accepted

Watch-outs

Higher entry price than many compounded GLP-1 services, and tirzepatide reaches $549 a month at the top dose
Available in 36 states only, and does not accept patients with diabetes
Semaglutide tablets are priced as $299 on one page and $299–$399 on another
The refund window is described two different ways across its own pages
Under-the-tongue GLP-1 tablets have no published human absorption data
NAD⁺ marketing claims outrun the evidence

Best for

Readers in a served state who want the full dose-by-dose cost and the dispensing pharmacies in view before they commit, and who will pay more for that clarity.

Who should look elsewhere

Anyone with diabetes, anyone outside Willow's 36 states, and buyers looking for the lowest compounded GLP-1 price.

The evidence behind what Willow prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
GLP-1 pill vs injection: what you trade for swallowing it
Oral semaglutide 50 mg matched the injection to within 0.2 of a percentage point — but not at the approved dose, and the daily fasting protocol is the cost nobody mentions.
NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

How Willow compares

A few alternatives worth a look, depending on what you’re optimizing for.

MEDGm
Readers who want compounded and brand-name GLP-1 routes presented side by side
See MEDGm →
Mondae
Buyers who want a low, honest month-to-month price with the compounding source named
See Mondae →
Shed
A wide range of GLP-1 formats (injection, drops, lozenges, microdose)
See Shed →

Compare all providers side by side →

More GLP-1 telehealth reviews: NEUVÉ HealthNex Gen Health RxNovaOria MedsRENN HealthSexyMD

Nadia Feldman

Access & cost · Reviewed and last verified September 2026

How we assessed this. This review reflects Aminoscope’s own read of Willow’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

How much does Willow cost at higher doses?: Willow publishes the full ladder. Semaglutide injection is $299 a month at every dose up to 3.5 mg and $399 at 7 mg. Tirzepatide injection is $399 at the three lowest doses (2.125, 4.25 and 6.375 mg), $499 at 8.5 and 11 mg, $524 at 13.5 mg and $549 at 17 mg. Tirzepatide tablets are $399 at 6 and 10 mg and $459 at 20 mg. Each figure is a monthly subscription price with medication, the physician and shipping included.
Which states does Willow serve?: Thirty-six, according to its FAQ: Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin and Wyoming. Its help center gives a slightly different list, with Puerto Rico in place of Wyoming, and New Mexico and Vermont appear neither on the FAQ list nor on the About page's list of states not yet served. Confirm your state with Willow before starting the questionnaire.
Can I use Willow if I have type 2 diabetes?: No. Willow states that it cannot currently accept patients with diabetes, although pre-diabetes and high blood pressure are accepted. That rules out a large group of people for whom GLP-1 drugs are commonly prescribed, so if you have diabetes, a service that treats it, or your own doctor, is the route.
What happens if I want to cancel or get a refund?: You cancel by messaging the care team, and the subscription is not locked in. To avoid the next charge, cancel at least two business days before your next processing date. On refunds, Willow's pages differ: the FAQ and help center promise a full refund if you cancel before the prescription is sent to the pharmacy, while the refund section of its consent form limits full refunds to cancellations within 24 hours of the order. Once medication is compounded or shipped, it cannot be returned. Ask the care team in writing which rule applies before you pay.
Is Willow's $299 a good price for compounded semaglutide?: It is at the upper end. Mondae charges $87 a month month-to-month for compounded semaglutide, and MEDGm lists injections from $179 and tablets from $249. What the higher price buys at Willow is a published price for every dose, the pharmacies named with addresses, a named prescribing practice, and physician messaging included, with no prepay commitment. Whether that is worth roughly $120 to $210 a month more is a judgment only you can make.
Can I get NAD⁺ from Willow without a GLP-1?: The site does not say. The NAD⁺ page lists a $199 monthly price and a dosing schedule, but its sign-up steps are headed "three simple steps to weight loss care", and Willow's help article on NAD⁺ describes it as support during GLP-1 treatment. Ask before you start the questionnaire. On the evidence, injected NAD⁺ has no controlled human outcome trials, so treat the energy and complexion claims as marketing.
Is Willow legit?: Willow is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide, Compounded tirzepatide and an oral form. Its stated availability: 36 states listed. What it publishes up front: Semaglutide injection or tablet from $299/mo; tirzepatide $399–$549/mo by dose. Month-to-month, 36 states. It is cash-pay and states it does not bill insurance. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. Those are the provider's own published claims rather than checks we could run ourselves, so get the ones that matter to you confirmed in writing before you pay.
Is Willow expensive compared with other GLP-1 telehealth providers?: Willow publishes a starting figure of $299/mo. Across the 51 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $299 with a median of $179, which puts Willow above the median. The other 33 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Check availability →

Or compare every GLP-1 provider.